# Intraperitoneal Chemotherapy and Systemic Chemotherapy Versus Systemic Chemotherapy After Curative Resection of Serosa-positive Gastric Cancer

> **NCT02205008** · PHASE3 · UNKNOWN · sponsor: **Kyungpook National University Hospital** · enrollment: 230 (estimated)

## Conditions studied

- Advanced Gastric Cancer With Serosal Invasion

## Interventions

- **PROCEDURE:** surgery
- **DRUG:** adjuvant systemic chemotherapy
- **DRUG:** Early postoperative intraperitoneal chemothgerapy

## Key facts

- **NCT ID:** NCT02205008
- **Lead sponsor:** Kyungpook National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2015-12
- **Final completion:** 2018-11
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2014-07-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02205008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02205008, "Intraperitoneal Chemotherapy and Systemic Chemotherapy Versus Systemic Chemotherapy After Curative Resection of Serosa-positive Gastric Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02205008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*